If you have any questions, call 1-855-XOFLUZA.
RxBIN: 600428
Group: 06780169
PCN: 06780000
Member ID: COUPON5
Genentech is currently honoring the XOFLUZA coupon until September 30, 2022, regardless of the expiration date printed on materials. Only one coupon may be used per script.
XOFLUZA. Prescribing information. Genentech USA, Inc.; 2021.
XOFLUZA. Prescribing information. Genentech USA, Inc.; 2021.
TAMIFLU. Prescribing information. Genentech USA, Inc.; 2019.
TAMIFLU. Prescribing information. Genentech USA, Inc.; 2019.
Hayden FG, Sugaya N, Hirotsu N, et al; Baloxavir Marboxil Investigators Group. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913-923.
Hayden FG, Sugaya N, Hirotsu N, et al; Baloxavir Marboxil Investigators Group. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913-923.
People at higher risk of flu complications. Centers for Disease Control and Prevention (CDC). Accessed September 9, 2021. https://www.cdc.gov/flu/highrisk/index.htm
People at higher risk of flu complications. Centers for Disease Control and Prevention (CDC). Accessed September 9, 2021. https://www.cdc.gov/flu/highrisk/index.htm
New CDC report: more than 100 million Americans have diabetes or prediabetes. CDC. Published July 18, 2017. Accessed September 9, 2021. https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
New CDC report: more than 100 million Americans have diabetes or prediabetes. CDC. Published July 18, 2017. Accessed September 9, 2021. https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
Most recent national asthma data. CDC. Accessed September 9, 2021. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm
Most recent national asthma data. CDC. Accessed September 9, 2021. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm
Basics about COPD. CDC. Accessed September 9, 2021. https://www.cdc.gov/copd/basics-about.html
Basics about COPD. CDC. Accessed September 9, 2021. https://www.cdc.gov/copd/basics-about.html
Heart disease. CDC. Accessed September 9, 2021. https://www.cdc.gov/nchs/fastats/heart-disease.htm
Heart disease. CDC. Accessed September 9, 2021. https://www.cdc.gov/nchs/fastats/heart-disease.htm
Flu vaccination coverage, United States, 2019-20 influenza season. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm
Flu vaccination coverage, United States, 2019-20 influenza season. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm
Ison MG, Portsmouth high-risk adolescent and adult outpatients with uncomplicated influenza (CAPTONSE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. Published online June 8, 2020. doi:10.1016/S1473-3099(20)30004-9
Ison MG, Portsmouth high-risk adolescent and adult outpatients with uncomplicated influenza (CAPTONSE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. Published online June 8, 2020. doi:10.1016/S1473-3099(20)30004-9
Supplement to: Ison MG, Portsmouth, S, Yoshida Y, et al. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2020;20(10)suppl:S8-S10.
Supplement to: Ison MG, Portsmouth, S, Yoshida Y, et al. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2020;20(10)suppl:S8-S10.
Clinical signs and symptoms of influenza. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/professionals/acip/clinical.htm
Clinical signs and symptoms of influenza. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/professionals/acip/clinical.htm
Ikematsu H, Hayden FG, Kawaguchi K, et al. Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med. 2020;383(4):309-320. doi:10.1056/NEJMoa1915341
Ikematsu H, Hayden FG, Kawaguchi K, et al. Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med. 2020;383(4):309-320. doi:10.1056/NEJMoa1915341
Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med. 2009;82(4):153-159.
Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med. 2009;82(4):153-159.
Influenza antiviral medications: summary for clinicians. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm#Table1
Influenza antiviral medications: summary for clinicians. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm#Table1
De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695-747.
De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695-747.
Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committeeon Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(1):1-24.
Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committeeon Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(1):1-24.
von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov. 2007;6(12):967-974. doi:10.1038/nrd2400
von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov. 2007;6(12):967-974. doi:10.1038/nrd2400
Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2019-2020 influenza season. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/about/burden/2019-2020.html
Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2019-2020 influenza season. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/about/burden/2019-2020.html
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Updated July 8, 2021. Accessed September 9, 2021. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Updated July 8, 2021. Accessed September 9, 2021. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
What is the difference between influenza (flu) and COVID-19? CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm
What is the difference between influenza (flu) and COVID-19? CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm
Cold versus flu. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/symptoms/coldflu.htm
Cold versus flu. CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/symptoms/coldflu.htm
COVID data tracker. CDC. Accessed September 9, 2021. https://covid.cdc.gov/covid-data-tracker/#cases_ casesinlast7days
COVID data tracker. CDC. Accessed September 9, 2021. https://covid.cdc.gov/covid-data-tracker/#cases_ casesinlast7days
Common colds: protect yourself and others. CDC. Published 2020. Accessed September 9, 2021. https://www.cdc.gov/features/rhinoviruses/index.html
Common colds: protect yourself and others. CDC. Published 2020. Accessed September 9, 2021. https://www.cdc.gov/features/rhinoviruses/index.html
Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291-300. doi:10.1016/s1473-3099(09)70069-6
Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291-300. doi:10.1016/s1473-3099(09)70069-6
Symptoms of COVID-19. CDC. Updated May 13, 2020. Accessed September 9, 2021. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Symptoms of COVID-19. CDC. Updated May 13, 2020. Accessed September 9, 2021. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
Key facts about influenza (flu). CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/about/keyfacts.htm
Key facts about influenza (flu). CDC. Accessed September 9, 2021. https://www.cdc.gov/flu/about/keyfacts.htm
Data on File. Genentech. 2021.
Data on File. Genentech. 2021.
Data on File, Genentech. 2020.
Data on File, Genentech. 2020.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.